Related Experiment Video
Updated: Mar 9, 2026

06:04
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
673
Implementing the Transcatheter Aortic Valve Replacement Heart Team: Complementary, Not Competitive, to Surgical
Xiaoying Lou1, Jessica Forcillo1, Vinod H Thourani1
1Division of Cardiothoracic Surgery, Joseph B. Whitehead Department of Surgery, Structural Heart and Valve Center, Emory University School of Medicine, Atlanta, Georgia.
Seminars in Thoracic and Cardiovascular Surgery
|January 4, 2017
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
528
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
528
Mitral Stenosis III: Medical Management
399
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
399
Heart Failure VI: Adjunct Therapies
493
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
493

